How to use the speech recognition tool?
Efficacy Study of GS010 for Treatment of Vision Loss From 7 Months to 1 Year From Onset in LHON Due to the ND4 Mutation.
Status of the trial: Completed
Orphan Drug Recognition: No
Inclusion: Patients with Leber hereditary optic neuropathy (LHON) carrying the m.11778G>A mitochondrial DNA mutationcarrying the m.11778G>A mitochondrial DNA mutation
Exclusion: Disease duration of more than one year in one or both eyes
Funder Type: industry
Principal location of the trial
HCP: Principal investigators
HCP: Other investigators